MycoBiomDB – Record Details (MyCo_3145)

Biomarker Record Details

Database ID: MyCo_3145
DB IDMyCo_3145
TitleEffects of host response and antifungal therapy on serum and BAL levels of galactomannan and (1→3)-β-D-glucan in experimental invasive pulmonary aspergillosis
Year2015
PMID26129890
Fungal Diseases involvedInvasive pulmonary aspergillosis
Associated Medical ConditionNone
GenusAspergillus
Speciesspp.
OrganismAspergillus spp.
Ethical StatementThe procedures involving an-imals conformed to the Guide for the Care and Use of Laboratory Animals by the Institute for Laboratory Ani-mal Research, Division of Earth and Life Studies, National Research Council, and approval by the Animal Care and Use Committee of the National Cancer Institute.
Site of InfectionNone
Opportunistic invasiveInvasive
Sample typeBody fluid
Sample sourceSerum
Host GroupAnimal
Host Common nameRabbit
Host Scientific nameOryctolagus cuniculus
Biomarker NameBDG
Biomarker Full Name1-3-beta-D-Glucan
Biomarker TypeDiagnostic
BiomoleculeProtein
Geographical LocationUSA
CohortFemale New Zealand White rabbits (Covance Research Products, Inc., Denver, PA) (n= 30) weighing 2.8–3.6 kg were individually housed in facilities accredited by the As- sociation for Assessment and Accreditation of Laboratory Animal Care International.
Cohort No.30
Age GroupNone
P Valuep<.05
SensitivityNone
SpecificityNone
Positive Predictive ValueNone
MICNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismNone
TechniqueELISA
Analysis MethodFDA Approved-Fungitell assay
ELISA kitsELISA Kit- PlateliaTM Aspergillus EIA, Bio-Rad Laboratories Red-mond, WA
Assay DataFDA- Fungitell®, Cape Cod International, Inc.; Falmounth, MA, USA
Validation Techniques usedFDA Approved-Fungitell assay, FDA Approved -Platelia Aspergillus Ag ELISA
Up Regulation Down RegulationIncrease
Sequence DataNone
External LinkNone